MagnaPharm Baltics UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
0 |
0 |
0 |
0 |
2022 |
---|
0 |
0 |
-25,615 |
-25,615 |
-25,615 |
- |
- |
-20,615 |
117,110 |
0 |
96,495 |
2023 |
---|
814,264 |
183,393 |
-241,519 |
-241,519 |
-54,396 |
56.50 |
-29.66 |
-262,134 |
519,499 |
26,966 |
313,524 |
Register and
explore Okredo data2023 |
---|
814,264 |
183,393 |
-241,519 |
-241,519 |
-54,396 |
56.50 |
-29.66 |
-262,134 |
519,499 |
26,966 |
313,524 |
Register and
explore Okredo data2023
Turnover (€)
814,264 €- *
Sales per employee (€)
183,393 €- *
Profit before tax (€)
-241,519 €-843 % *
Net Profit (€)
-241,519 €-843 % *
Profit per employee (€)
-54,396 €-112 % *
Total profitability (%)
56.50 %- *
Net profitability (%)
-29.66 %- *
Equity (€)
-262,134 €-1,172 % *
Amounts Payable And Liabilities (€)
519,499 €344 % *
Non-current Assets (€)
26,966 €- *
CurrentAssets (€)
313,524 €225 % *